Request an Appointment Call 800-525-2225 Available Monday through Friday, 8 a
We aimed to determine whether adjuvant capecitabine improved overall survival compared with observation following surgery for biliary tract cancer
Cholangiocarcinoma (CCA) is the second most common
Purpose: The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown
On December 14, 2022, the Food and Drug Administration approved updated labeling for capecitabine tablets (Xeloda, Genentech, Inc
Community members on Thursday were grieving the death of a 9-year-old boy who sustained major injuries in a traffic collision
The two eCCA
Bile duct cancer (also called cholangiocarcinoma) can occur in the bile ducts in the liver (intrahepatic) or outside the liver (perihilar or distal )
2,3 Complete
May have been due to post surgical (11) weeks ago gastroparesis
has taken me off chemo and suggested I go on Xeloda (Capecitabine)
A stop of progression, documented by imaging procedures and tumor marker kinetics, was achieved in both patients
Patients and Methods Eligibility criteria included diagnosis of
The most common types of chemotherapy drugs are: gemcitabine and cisplatin
It is a treatment for: bowel cancer (colorectal cancer) cancer of the food pipe (oesophagus) stomach cancer
S0809 was designed to estimate 2-year survival (overall and after R0 or R1 resection), pattern of relapse, and toxicity in patients treated with this adjuvant regimen
Adjuvant treatment of biliary tract (cholangiocarcinoma or muscle-invasive gallbladder) cancer after complete resection of the primary tumour
The incidence and epidemiology of biliary tract cancer are fluid and complex
Most patients are diagnosed with locally advanced or metastatic disease, and survival outcomes remain poor
mbachini